We are live on
!
Find out more
PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Est. Return
26.5%
This Fund
S&P 500
This Quarter
Est. Return
-2.87%
1 Year Est. Return
+26.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$67.4B
AUM Growth
-$4.5B
(-6.3%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
1,643
New
69
Increased
632
Reduced
516
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$156M |
| 2 |
Amazon
AMZN
|
+$104M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$79.1M |
| 4 |
Eversource Energy
ES
|
+$73.2M |
| 5 |
Exelon
EXC
|
+$67.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$159M |
| 2 |
Meta Platforms (Facebook)
META
|
+$120M |
| 3 |
Avantor
AVTR
|
+$108M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$99.1M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$97.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.43% |
| 2 | Healthcare | 16.31% |
| 3 | Industrials | 15.57% |
| 4 | Utilities | 11.18% |
| 5 | Consumer Discretionary | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
O'Reilly Automotive
ORLY
$74.5B
| $41M | 0.06% |
875,355
-197,595
| -18% | -$9.21M |
|
302
Goldman Sachs
GS
$302B
| $41M | 0.06% |
139,962
+1,208
| +0.9% | +$391K |
|
303
Pinterest
PINS
$13B
| $40.7M | 0.06% |
1,748,702
+115,873
| +7% | +$2.54M |
|
304
Tractor Supply
TSCO
$19B
| $40.7M | 0.06% |
1,186,520
+54,110
| +5% | +$2.11M |
|
305
Zurn Elkay Water Solutions
ZWS
$8.46B
| $40.5M | 0.06% |
1,654,837
+318
| +0% | +$9.06K |
|
306
Trane Technologies
TT
$105B
| $40M | 0.06% |
276,059
-17,840
| -6% | -$2.67M |
|
307
NiSource
NI
$20.1B
| $39.8M | 0.06% |
1,578,994
+46,738
| +3% | +$1.38M |
|
308
Pultegroup
PHM
$24.6B
| $39.3M | 0.06% |
1,048,932
-32,174
| -3% | -$1.35M |
|
|
ITCI
309
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $39.3M | 0.06% |
844,924
-268,658
| -24% | -$14M |
|
310
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $39M | 0.06% |
3,037,861
-493,941
| -14% | -$5.63M |
|
311
Arcus Biosciences
RCUS
$3.69B
| $39M | 0.06% |
1,489,443
-423,108
| -22% | -$11.2M |
|
312
iShares Global Consumer Staples ETF
KXI
$1.06B
| $39M | 0.06% |
726,750
+30,327
| +4% | +$1.77M |
|
|
ATVI
313
DELISTED
Activision Blizzard
ATVI
| $38.8M | 0.06% |
521,789
+6,131
| +1% | +$480K |
|
314
Etsy
ETSY
$7.31B
| $38.4M | 0.06% |
383,573
+21,678
| +6% | +$2.21M |
|
315
Middleby
MIDD
$5.38B
| $38.2M | 0.06% |
298,044
-24,234
| -8% | -$3.4M |
|
316
Iovance Biotherapeutics
IOVA
$3.05B
| $38.2M | 0.06% |
3,982,344
+349,506
| +10% | +$4.03M |
|
317
Cooper Companies
COO
$15B
| $38M | 0.06% |
576,500
-251,900
| -30% | -$19.3M |
|
|
VTYX
318
DELISTED
Ventyx Biosciences
VTYX
| $37.4M | 0.06% |
+1,071,983
| New | +$23.7M |
|
319
Gulfport Energy Corp
GPOR
$3B
| $37.3M | 0.06% |
422,749
| – | – |
|
|
ONC
320
BeOne Medicines Ltd
ONC
$40.6B
| $37.3M | 0.06% |
276,418
-32,501
| -11% | -$5.58M |
|
321
Guardant Health
GH
$22.2B
| $36.8M | 0.05% |
682,957
-351,695
| -34% | -$18.1M |
|
322
Illinois Tool Works
ITW
$83.3B
| $36.6M | 0.05% |
202,841
-2,238
| -1% | -$442K |
|
323
Chubb
CB
$132B
| $36.5M | 0.05% |
200,754
-252
| -0.1% | -$47.9K |
|
|
FOLD
324
DELISTED
Amicus Therapeutics
FOLD
| $36.4M | 0.05% |
3,485,302
+2,842,220
| +442% | +$31.7M |
|
|
LHCG
325
DELISTED
LHC Group LLC
LHCG
| $36.4M | 0.05% |
222,318
-20,856
| -9% | -$3.38M |
|
Similar funds
TF
TAIM
V
PI
WI
VIA
EST
TCM
Pictet Asset Management (Switzerland)'s Q3 2022 Portfolio in Review
As of Q3 2022, Pictet Asset Management (Switzerland) held 1,643 positions worth $67.4B, down 6.3% from $71.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Pictet Asset Management (Switzerland)'s Q3 2022 filing shows 69 new, 632 increased, 516 reduced and 78 closed positions. Its largest new stake was Ventyx Biosciences: 1,071,983 shares worth $37.4M. The largest sale was ZENDESK INC, an estimated $159M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
- Pictet Asset Management (Switzerland)'s largest Q3 2022 buy was Ventyx Biosciences: 1,071,983 shares worth $37.4M.
- Pictet Asset Management (Switzerland) added most to Weyerhaeuser in Q3 2022, an estimated $156M increase.
- Pictet Asset Management (Switzerland)'s biggest Q3 2022 reduction was ZENDESK INC, cutting an estimated $159M.
- Pictet Asset Management (Switzerland) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $32M.
- Pictet Asset Management (Switzerland)'s ten largest holdings make up 15% of its $67.4B portfolio in Q3 2022.
- Pictet Asset Management (Switzerland) opened 69 new positions and closed 78 in Q3 2022.
- Pictet Asset Management (Switzerland)'s portfolio value fell 6.3% quarter-over-quarter to $67.4B.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.